State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse

REFERENCES

• Kiyatkin EA. Brain temperature homeostasis: physiological fluctuations and pathological shifts. Front Biosci 2010; 15:73-92.
   PubMed Web of Science ®Google Scholar
• Abrams R, Hammel HT. Hypothalamic temperature in unanesthetized albino rats during feeding and sleeping. Am J Physiol 1964; 206:641-6.
   PubMed Web of Science ®Google Scholar
• Baker MA, Frye FM, Millet VE. Origin of temperature changes evoked in the brain by sensory stimulation. Exp Neurol 1973; 38:502-19.
   PubMed Web of Science ®Google Scholar
• Delgado JMR, Hanai T. Intracerebral temperatures in free-moving cats. Am J Physiol 1966; 211:755-69.
   PubMed Web of Science ®Google Scholar
• Fuller CA, Baker MA. Selective regulation of brain and body temperatures in the squirrel monkey. Am J Physiol 1983; 245:R293-7.
   PubMed Web of Science ®Google Scholar
• Hayward JN, Baker MA. Role of cerebral blood flow in the regulation of brain temperature In the monkey. Am J Physiol 1968; 215:389-403.
   PubMed Web of Science ®Google Scholar
• Kovalson VM. Brain temperature variations during natural sleep and arousal in white rats. Physiol Behav 1972; 10:667-70.
   Web of Science ®Google Scholar
• McElligott JC, Melzack R. Localized thermal changes evoked in the brain by visual and auditory stimulation. Exp Neurol 1967; 17:293-312.
   PubMed Web of Science ®Google Scholar
• Serota HM, Gerard RM. Localized thermal changes in cat's brain. J Neurophysiol 1938; 1:115-24.
   Google Scholar
• Smirnov MS, Kiyatkin EA. Fluctuations in central and peripheral temperatures associated with feeding behavior in rats. Am J Physiol 2008; 295:R1414-24.
   Google Scholar
• Kiyatkin EA, Mitchum R. Fluctuations in brain temperatures during sexual behavior in male rats: An approach for evaluating neural activity underlying motivated behavior. Neuroscience 2003; 119:1169-83.
   PubMed Web of Science ®Google Scholar
• Rumana CS, Gopinath SP, Uzura M, Valadka AB, Robertson CS. Brain temperatures exceed systemic temperatures in head-injured patients. Clin Care Med 1998; 26:562-7.
   PubMed Web of Science ®Google Scholar
• Mariak Z, Jadeszko M, Lewko J, Lebkowski W, Lyson T. No specific brain protection against thermal stress in fever. Acta Neurochir (Wien) 1998; 140:585-90.
   PubMed Web of Science ®Google Scholar
• Mariak Z, Lebkowski W, Lyson T, Lewko J, Piekarski P. Brain temperature during craniotomy in general anesthesia. Neurol Neurochir Pol 1999; 33:1325-7.
   PubMedGoogle Scholar
• Mariak Z, Lyso, T, Peikarski P, Lewko J, Jadeszko M, Szydlik P. Brain temperature in patients with central nervous system lesions. Neurol Neurosurg Pol 2000; 34:509-22.
   PubMedGoogle Scholar
• Rango M, Arighi A, Bonifati C, Bresolin N. Increased brain temperature in Parkinson's disease. NeuroReport 2012; 23:129-33.
   PubMed Web of Science ®Google Scholar
• Rango M, Arighi A, Bonifati C, Del Bo R, Comi G, Bresolin N. The brain is hypothermic in patients with mitochondrial diseases. J Cereb Blood Flow Metab 2014; 34:915-920.
   PubMed Web of Science ®Google Scholar
• Sukstanskii AL, Yablonskiy DA. Theoretical model of temperature regulation in the brain during changes in functional activity. Proc Natl Acad Sci USA 2006; 103:12144-9.
   PubMed Web of Science ®Google Scholar
• Armenian P, Mamantov TM, Tsutaoka BT, Gerona RR, Silman EF, Wu AH, Olson KR. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med 2013; 28:252-8.
   PubMedGoogle Scholar
• Dafters RI. Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 1995; 58:877-82.
   PubMed Web of Science ®Google Scholar
• Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Can Med Ass J 2001; 165:917-28.
   PubMed Web of Science ®Google Scholar
• Nimmo SM, Kennedy BW, Tullett WM, Blyth AS. Dougall JR. Drug-induced hyperthermia. Anesthesia 1993; 48:892-5.
   PubMed Web of Science ®Google Scholar
• Nybo L, Secher NH, Nielson B. Inadequate heat release from the human brain during prolonged exercise with hyperthermia. J Physiol 2002; 545:697-704.
   PubMed Web of Science ®Google Scholar
• Nybo L. Hyperthermia and fatigue. J Appl Physiol 2008; 104:871-7.
   PubMed Web of Science ®Google Scholar
• Schmidt-Nielsen K. Animal Physiology. Adaptation and Environment. 5th Edition. Cambridge: Cambridge University Press, 1997.
   Google Scholar
• Siesjo B. Brain Energy Metabolism. New York: Wiley, 1978.
   Google Scholar
• Feitelberg S, Lampl H. Warmetonung der Grosshirnrinde bei Erregung und Ruhe. Functionshemmung. Arch Exp Path Pharmak 1935; 177:726-36 (in German).
   Google Scholar
• Kiyatkin EA, Brown PL, Wise RA. 2002. Brain temperature fluctuation: a reflection of functional neural activation. Eur J Neurosci 2002; 16:164-68.
   PubMed Web of Science ®Google Scholar
• Kuhar MJ, Ritz MC, Boja JM. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991; 14:299-302.
   PubMed Web of Science ®Google Scholar
• Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94:469-92.
   PubMed Web of Science ®Google Scholar
• Pickens R, Thompson T. Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed–ratio size. J Pharmacol Exp Ther 1968; 16:122-9.
   Google Scholar
• Brown PL, Kiyatkin EA. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats. Eur J Neurosci 2005; 22:930-8.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA. Brain temperature responses to salient stimuli persis during dopamine receptor blockade despite a blockade of locomotor responses. Pharmacol Biochem Behav 2008; 91:233-42.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Brown PL. Fluctuations in neural activity during cocaine self-administration: Clues provided by brain thermorecording. Neuroscience 2003; 116:525-38.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Brown PL. Brain temperature fluctuations during repeated passive vs. active cocaine administration: Clues for understanding the pharmacological determination of drug-taking behavior. Brain Res 2004; 1005:101-16.
   PubMed Web of Science ®Google Scholar
• Wilder J. The law of initial values in neurology and psychiatry; facts and problems. J Nerv Ment Dis 1957; 125:73-86.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Stein EA. Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: an electrochemical study. Neuroscience 1995; 64:599-617.
   PubMed Web of Science ®Google Scholar
• Alberts DS, Sonsalla PK. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 1995; 275:1104-14.
   PubMed Web of Science ®Google Scholar
• Freedman RR. Johanson C-E. Tancer ME. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 2005; 183:248-56.
   PubMed Web of Science ®Google Scholar
• Gordon CJ, Watkinson WP, O’Callaghan PP, Miller DB. Effects of 3,4-methylenedioxymetamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 1991; 38:339-44.
   PubMed Web of Science ®Google Scholar
• Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacol Rev 2003; 55:463-508.
   PubMed Web of Science ®Google Scholar
• Mechan AO, Esteban B, O’Shea E, Elliott JM, Colado MI, Green AR. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenediomethamphetamine (MDMA, “ecstasy”) to rats. Br J Pharmacol 2002; 135:170-80.
   PubMed Web of Science ®Google Scholar
• Sandoval V, Hanson GR, Fleckenstein AE. Methamphetamine decreases mouse striatal dopamine transport activity: roles of hyperthermia and dopamine. Eur J Pharmacol 2000; 409:265-71.
   PubMed Web of Science ®Google Scholar
• Von Huben RD, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA. Impact of ambient temperature on hyperthermia induced by (+/-)3,4- methylenediomethamphetamine in rhesus macaques. Neuropsychopharmacology 2007; 32:673-81.
   PubMed Web of Science ®Google Scholar
• Ali SF, Newport GD, Holson RR, Slikker W, Bowyer JF. Low environmental temperatures or pharmacological agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 1994; 658:33-8.
   PubMed Web of Science ®Google Scholar
• Davidson C, Gow AJ, Lee TH, Ellinwood EH. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 2001; 36:1-22.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Geddes TJ. Molecular footprints of neurotoxic amphetamine action. Ann NY Acad Sci 2008; 914:92-103.
   Google Scholar
• Schmued LC. Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 2003; 974:127-33.
   PubMed Web of Science ®Google Scholar
• Seiden LS, Sabol KE. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 1996; 163:251-76.
   PubMedGoogle Scholar
• Pederson NP, Blessing WW. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) on conscious rabbits. J Neurosci 2001; 21:8648-54.
   PubMed Web of Science ®Google Scholar
• Brown PL, Wise RA, Kiyatkin E.A. Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J Neurosci 2003; 23:3924-9.
   PubMed Web of Science ®Google Scholar
• Romanovsky AA, Ivanov AI, Shimansky YP. Ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 2002; 92:2667-79.
   PubMed Web of Science ®Google Scholar
• Brown PL, Kiyatkin EA. Brain hyperthermia induced by MDMA (“ecstasy”): modulation by environmental conditions. Eur J Neurosci 2004; 20:51-8.
   PubMed Web of Science ®Google Scholar
• Davis WM, Hatoum HT, Walters IW. Toxicity of MDA (2.4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse. Alcohol Drug Res 1987; 7:123-34.
   PubMedGoogle Scholar
• Yamamoto BK, Zhu W. The effect of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998; 287:107-14.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR. Psychoactive “bath salts”: not so soothing. Eur J Pharmacol 2013; 698:1-5.
   PubMed Web of Science ®Google Scholar
• German et al., 2014 German CL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 2014; 97:2-8.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49:499-505.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012; 8:33-42.
   PubMedGoogle Scholar
• Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA. Psychoactive “bath salts” intoxication with methylenedioxypyrovalerone. Am J Med 2012; 125:854-8.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Ayestas MA, Jr., Partilla JS, Sink JR, Shulgin AT, Daley PF, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2012; 37:1192-203.
   PubMed Web of Science ®Google Scholar
• Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A. Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 2013; 85:1803-15.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013; 168:458-70.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, et al. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 2013; 38:552-62.
   PubMed Web of Science ®Google Scholar
• Cameron KN, Kolanos R, Solis E, Jr., Glennon RA, De Felice LJ. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 2013; 168:1750-57.
   PubMed Web of Science ®Google Scholar
• Pearson JM, Hargraves TL, Hair LS, Massucci CJ, Frazee CC, 3rd, Garg U, et al. Three fatal intoxications due to methylone. J Anal Toxicol 2012; 36:444-451.
   PubMed Web of Science ®Google Scholar
• Borek HA, Holstege CP. Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 2012; 60:103-5.
   PubMed Web of Science ®Google Scholar
• Kesha K, Boggs CL, Ripple MG, Allan CH, Levine B, Jufer-Phipps R, et al. Methylenedioxypyrovalerone (“bath salts”), related death: case report and review of the literature. J Forensic Sci 2013; 58: 1654-9.
   PubMed Web of Science ®Google Scholar
• Murray BL, Murphy CM, Beuhler MC. Death following recreational use of designer drug “bath salts” containing 3,4-Methylenedioxypyrovalerone (MDPV). J Med Toxicol 2012; 8:69-75.
   PubMedGoogle Scholar
• Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 2013; 71: 130-40.
   PubMed Web of Science ®Google Scholar
• Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC. In vivo effects of abused ‘bath salt’ constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 2013; 38:563-73.
   PubMed Web of Science ®Google Scholar
• Merluzzi AP, Hurwitz ZE, Briscione MA, Cobuzzi JL, Wetzell B, Rice KC, et al. Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats. Dev Psychobiol 2013; 56:943-54.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y. Critical role of peripheral vasoconstriction in fatal brain hypewrthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use. J Neurosci 2014; 34:7754-62.
   PubMed Web of Science ®Google Scholar
• Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y. Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Neuropsychopharmacology 2014; in press
   PubMed Web of Science ®Google Scholar
• Gordon CJ. Thermal biology of the laboratory rat. Physiol Behav 1990; 47:963-91.
   PubMed Web of Science ®Google Scholar
• Rowell LB. Cardiovascular aspects of human thermoregulation. Circ Res 1983; 52:367-79.
   PubMed Web of Science ®Google Scholar
• Banks ML, Sprague JE, Kisor DF, Czoty PW, Nichols DE, Nader MA. Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced theremodysregulation and pharmacokinetics in male monkeys. Drug Metab Dispos 2007; 35:1840-5.
   PubMed Web of Science ®Google Scholar
• Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN. Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys, Drug Alcohol Depend 2006; 20:276-81.
   Web of Science ®Google Scholar
• Parrott AC. The potential dangers of using MDMA for psychotherapy. J Psychoactive Drugs 2014; 46:37-43.
   PubMed Web of Science ®Google Scholar